Guidance

Wholesalers & manufacturers guidance following agreement of the Windsor Framework

Actions QPs, RPis and RPs need to take following agreement of the Windsor Framework

Documents

Windsor Framework disapplication of EU falsified medicines directive Q&A

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Windsor Framework wholesaler and manufacturer Q&A

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Guidance to support manufacturers and wholesale dealers authorised by the MHRA and the associated qualified persons (QPs), responsible persons (RPs) and responsible persons for import (RPis), in order to implement the arrangements of the Windsor Framework for human medicines.

Updates to this page

Published 12 September 2024
Last updated 11 March 2025 show all updates
  1. Updated to remove footnote: “1. Subject to the UK providing written guarantees to the European Commission as provided for in Article 8 of EU Regulation 2023/1182 and following the entry into force and application procedure provided for in Article 14" from Wholesalers & manufacturers guidance following agreement of the Windsor Framework attachment.

  2. Updated the document Wholesalers & manufacturers guidance following agreement of the Windsor Framework to add Windsor Framework Wholesaler and Manufacturers Q&A and FMD Q&A

  3. First published.

Sign up for emails or print this page